Select Page

PMBCL

Articles

– Post-therapy –  

2014 Martelli et al.

FDG PET predicts survival after Chemoimmunotherapy for PMBCL - Results of the International Extranodal Lymphoma Study Group IELSG-26 Study

2014 Prochazka et al.

Prognostic Impact of Interim and Final PET in Primary Mediastinal Large B-Cell Lymphoma Treated with Intensive Etoposide-Based Therapy

2014 Nagle et al.

The role of FDG-PET imaging as a prognostic marker of outcome in PMBCL

2015 Svoboda et al.

Brentuximab Vedotin in Combination with Multi-Agent Chemotherapy Is Well Tolerated and Shows Promising Activity As Frontline Treatment for Primary Mediastinal B-Cell Lymphoma

2015 Vassilakopoulos et al.

A 'PET' topic in primary mediastinal large Bcell lymphoma: positive or negative, and how to handle it in the end

2016 Kocurek et al.

Primary mediastinal B-cell lymphoma – metabolic and anatomical features in 18FDG-PET/CT and response to therapy

2017 Zinzani et al.

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

2018 Giulino-Roth

How I Treat Primary Mediastinal B-cell Lymphoma

2019 Tomassetti et al.

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma

CATEGORIES